comparemela.com

Latest Breaking News On - Sam slutsky - Page 2 : comparemela.com

Rain Therapeutics Inc (NASDAQ:RAIN) Q1 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

United statesJoe catanzaroTony butlerSam slutskyMitchell kapoorYigal nochomovitzNelson cabatuanRichard bryceGraig suvannavejhRobert doebeleMichael schmidtFaisal khurshidBob doebelePiper sandlerJeff jonesAvantika joshi

InflaRx (IFRX) Gets a Buy from SVB Securities

In a report released on April 4, Joseph Schwartz from SVB Securities reiterated a Buy rating on InflaRx (IFRX – Research Report), with a p.

Sam slutskyRenfeng guoNiels christoph riedemannJoseph schwartzNicolas fulpiusCredit suisseResearch reportSarepta therapeuticsBiomarin pharmaceuticalLifesci capital

InflaRx (IFRX) was upgraded to a Buy Rating at LifeSci Capital

InflaRx (IFRX – Research Report) received a Buy rating and price target from LifeSci Capital analyst Sam Slutsky today. The company&#821.

Sam slutskyRenfeng guoNiels christoph riedemannNicolas fulpiusResearch reportLifesci capitalBrain therapeuticsCogent biosciencesStrong buy

Ventyx Biosciences, Inc (VTYX) Q3 2022 Earnings Call Transcript

Ventyx Biosciences, Inc. (NASDAQ:NASDAQ:VTYX) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Marty Auster - Chief Financial Officer Raju Mohan - Founder.

Raju mohanPiper sandlerMarty austerSwapnil malekarJeff jonesEmily bodnarSam slutskyAlex thompsonCompany participantsVentyx biosciences incVentyx biosciencesConference call novemberChief executiveChief medicalVentyx biosciences third quarterChief financial

vimarsana © 2020. All Rights Reserved.